Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,300 | 1 | 49.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,145 | 2 | 47.4% |
| Food and Beverage | $188.52 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $6,445 | 3 | $0 (2024) |
| Amgen Inc. | $94.40 | 1 | $0 (2017) |
| Fresenius Kabi USA, LLC | $78.39 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $15.73 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,300 | 1 | PFIZER INC. ($3,300) |
| 2020 | $3,145 | 2 | PFIZER INC. ($3,145) |
| 2017 | $188.52 | 3 | Amgen Inc. ($94.40) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/02/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| 09/03/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,775.00 | General |
| 11/29/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $94.40 | General |
| 10/19/2017 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $78.39 | General |
| Category: Nutrition | ||||||
| 01/05/2017 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: IMMUNOLOGY | ||||||
About Dr. Emily Fox, MD
Dr. Emily Fox, MD is a Pediatric Rheumatology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1538480074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Fox, MD has received a total of $6,634 in payments from pharmaceutical and medical device companies, with $3,300 received in 2024. These payments were reported across 6 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($3,300).
Practice Information
- Specialty Pediatric Rheumatology
- Other Specialties Pediatric Rheumatology, Pediatrics
- Location Kansas City, MO
- Active Since 06/18/2010
- Last Updated 08/05/2016
- Taxonomy Code 2080P0216X
- Entity Type Individual
- NPI Number 1538480074
Products in Payments
- XELJANZ (Drug) $3,300
- Smoflipid (Drug) $78.39
- ILARIS (Biological) $15.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Rheumatology Doctors in Kansas City
Ashley Cooper, Md, MD
Pediatric Rheumatology — Payments: $1,256
Mrs. Leslie Favier, M.d, M.D
Pediatric Rheumatology — Payments: $285.13
Mara Becker, M.d, M.D
Pediatric Rheumatology — Payments: $184.24
Maria Ibarra, M.d, M.D
Pediatric Rheumatology — Payments: $176.60
Dr. Cara Hoffart, D.o, D.O
Pediatric Rheumatology — Payments: $110.13
Dr. Michael Holland, Md, MD
Pediatric Rheumatology